NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 216 filers reported holding NEKTAR THERAPEUTICS in Q4 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,752 | -18.2% | 10,000 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $7,029 | -68.9% | 10,000 | 0.0% | 0.00% | -66.7% |
| Q4 2022 | $22,600 | -29.4% | 10,000 | 0.0% | 0.01% | -35.7% |
| Q3 2022 | $32,000 | -15.8% | 10,000 | 0.0% | 0.01% | -6.7% |
| Q2 2022 | $38,000 | -29.6% | 10,000 | 0.0% | 0.02% | -16.7% |
| Q1 2022 | $54,000 | -60.0% | 10,000 | 0.0% | 0.02% | -56.1% |
| Q4 2021 | $135,000 | -25.0% | 10,000 | 0.0% | 0.04% | -30.5% |
| Q3 2021 | $180,000 | +4.7% | 10,000 | 0.0% | 0.06% | +5.4% |
| Q2 2021 | $172,000 | -14.0% | 10,000 | 0.0% | 0.06% | -18.8% |
| Q1 2021 | $200,000 | +17.6% | 10,000 | 0.0% | 0.07% | +9.5% |
| Q4 2020 | $170,000 | +2.4% | 10,000 | 0.0% | 0.06% | -10.0% |
| Q3 2020 | $166,000 | -28.4% | 10,000 | 0.0% | 0.07% | -34.0% |
| Q2 2020 | $232,000 | +8.4% | 10,000 | -16.7% | 0.11% | -10.9% |
| Q1 2020 | $214,000 | -17.4% | 12,000 | 0.0% | 0.12% | +11.2% |
| Q4 2019 | $259,000 | +18.3% | 12,000 | 0.0% | 0.11% | +7.0% |
| Q3 2019 | $219,000 | -48.7% | 12,000 | 0.0% | 0.10% | -46.8% |
| Q2 2019 | $427,000 | +6.0% | 12,000 | 0.0% | 0.19% | +5.0% |
| Q1 2019 | $403,000 | +2.3% | 12,000 | 0.0% | 0.18% | -11.4% |
| Q4 2018 | $394,000 | – | 12,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
| Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
| Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
| TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
| NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
| Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
| HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
| Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
| Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
| FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |